Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2013 San Antonio Breast Cancer Symposium (SABCS)

9 - 11 Dec 2013
Henry B. Gonzalez Convention Center, San Antonio, Texas, United States of America
Symptom management and quality of life in metastatic breast cancer
Dr Polly Niravath - Baylor College of Medicine, Houston, Texas
Symptom management and quality of life in metastatic breast cancer ( Dr Polly Niravath - Baylor College of Medicine, Houston, Texas )
20 Dec 2013
The impact of biological age on breast cancer
Dr Alistair Ring - Brighton and Sussex Medical School, UK
The impact of biological age on breast cancer ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )
20 Dec 2013
Aspirin trialled for breast cancer recurrence prevention
Dr Alistair Ring - Brighton and Sussex Medical School, UK
Aspirin trialled for breast cancer recurrence prevention ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )
20 Dec 2013
Oncotype DX: changing breast cancer treatment
Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsbu...
Oncotype DX: changing breast cancer treatment ( Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA )
19 Dec 2013
Drop in breast cancer mortality in developed countries varies
Dr Donald Berry - MD Anderson Cancer Center, Houston, USA
Drop in breast cancer mortality in developed countries varies ( Dr Donald Berry - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013
Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast ...
Dr Barbara Fowble - University of California, San Francisco, USA
Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer ( Dr Barbara Fowble - University of California, San Francisco, USA )
19 Dec 2013
Translational studies of CDK and PARP inhibitors
Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013
HER2 positive breast cancer treatment, past and future
Dr Edith Perez - Mayo Clinic, Rochester, USA
HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
19 Dec 2013
Preventing metastases by tackling exosomes
Dr Jeff Wrana - University of Toronto, Canada
Preventing metastases by tackling exosomes ( Dr Jeff Wrana - University of Toronto, Canada )
19 Dec 2013
Moving breast cancer stem cell therapies to the clinic
Dr Max Wicha - University of Michigan, Ann Arbor, USA
Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
19 Dec 2013
Breast cancer psychosocial and survivorship issues: are we doing better?
Dr Lesley Fallowfield - University of Sussex, Brighton, UK
Breast cancer psychosocial and survivorship issues: are we doing better? ( Dr Lesley Fallowfield - University of Sussex, Brighton, UK )
19 Dec 2013
Male breast cancer: Opportunities for increased research funding and clinical tr...
Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
Male breast cancer: Opportunities for increased research funding and clinical trial access ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy
Dr Sibylle Loibl - German Breast Cancer Group
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy ( Dr Sibylle Loibl - German Breast Cancer Group )
19 Dec 2013
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogen...
Prof Adrian Harris - University of Oxford, Oxford, UK
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )
19 Dec 2013
Adjuvant bisphosphonate therapy in breast cancer
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant bisphosphonate therapy in breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
19 Dec 2013
Pain relief in breast cancer patients in Vietnam
Johnny Nguyen - University of Toronto, Canada
Pain relief in breast cancer patients in Vietnam ( Johnny Nguyen - University of Toronto, Canada )
19 Dec 2013
Careers in translational research
Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Careers in translational research ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013
Anastrozole cuts breast cancer cases by more than 50% in high risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
18 Dec 2013
Long term use of aromatase inhibitors and compliance
Prof Peter Barrett-Lee - Cardiff University, UK
Long term use of aromatase inhibitors and compliance ( Prof Peter Barrett-Lee - Cardiff University, UK )
18 Dec 2013
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers tr...
Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant ( Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany )
16 Dec 2013
Exercise improves drug-associated joint pain in breast cancer survivors
Prof Melinda Irwin - Yale Cancer Center, New Haven, USA
Exercise improves drug-associated joint pain in breast cancer survivors ( Prof Melinda Irwin - Yale Cancer Center, New Haven, USA )
16 Dec 2013
Benefit of breast cancer screening more consistent across studies than previousl...
Dr Robert Smith - American Cancer Society, Atlanta, USA
Benefit of breast cancer screening more consistent across studies than previously understood ( Dr Robert Smith - American Cancer Society, Atlanta, USA )
16 Dec 2013
Avoiding radiotherapy is an option for some older patients with breast cancer
Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK
Avoiding radiotherapy is an option for some older patients with breast cancer ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )
16 Dec 2013
Anastrozole cuts breast cancer cases by more than 50% in high risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
13 Dec 2013
Patients with metastatic breast cancer may not benefit from surgery and radiatio...
Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India.
Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy ( Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India. )
13 Dec 2013
Comment on HER2 research: NeoALTTO trial, BETH study and immune cell levels pre...
Dr Jennifer Litton - MD Anderson Cancer Center, Houston, USA
Comment on HER2  research: NeoALTTO trial, BETH study and immune cell levels predicting outcomes ( Dr Jennifer Litton - MD Anderson Cancer Center, Houston, USA )
12 Dec 2013
NeoALTTO trial indicates breast cancer patients who had pathologic complete resp...
Prof Martine Piccart-Gebhart - Jules Bordet Institute, Brussels, Belgium
NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival ( Prof Martine Piccart-Gebhart - Jules Bordet Institute, Brussels, Belgium )
12 Dec 2013
Immune cells in tumours may identify breast cancer patients most likely to benef...
Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab ( Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2013
BETH study: highly effective treatment option for patients with HER2 breast can...
Dr Dennis Slamon - University of California, Los Angeles
BETH study: highly effective treatment option for patients with HER2  breast cancer ( Dr Dennis Slamon - University of California, Los Angeles )
12 Dec 2013
Screening mammography, over diagnosis and over treatment
Dr Gilbert Welch - Dartmouth College, Hanover, USA
Screening mammography, over diagnosis and over treatment ( Dr Gilbert Welch - Dartmouth College, Hanover, USA )
12 Dec 2013